Cytomegalovirus retinitis after intravitreal triamcinolone acetonide in an immunocompetent patient

Jpn J Ophthalmol. 2008 Sep-Oct;52(5):414-416. doi: 10.1007/s10384-008-0576-0. Epub 2008 Nov 11.

Authors

Sekiryu Tetsuju¹, Tomohiro Iida², Hisatoshi Kaneko², Masaaki Saito²

Affiliations

¹ Department of Ophthalmology, Fukushima Medical University, Fukushima, Japan. sekiryu@fmu.ac.jp.
² Department of Ophthalmology, Fukushima Medical University, Fukushima, Japan.

PMID: 18991048
DOI: 10.1007/s10384-008-0576-0

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antiviral Agents / therapeutic use
Cytomegalovirus Retinitis / complications*
Cytomegalovirus Retinitis / diagnosis
Cytomegalovirus Retinitis / drug therapy
Diabetes Mellitus, Type 2 / complications
Fluorescein Angiography
Ganciclovir / therapeutic use
Glucocorticoids / administration & dosage*
Humans
Immunocompromised Host
Injections
Macular Edema / drug therapy
Male
Middle Aged
Opportunistic Infections / complications*
Opportunistic Infections / diagnosis
Opportunistic Infections / drug therapy
Retinal Vein Occlusion / drug therapy
Triamcinolone Acetonide / administration & dosage*
Vitreous Body

Substances

Antiviral Agents
Glucocorticoids
Triamcinolone Acetonide
Ganciclovir